Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Akero Therapeutics

Youtube Subscribe

...

Ticker: AKRO

Sector: Biotechnology

Akero Therapeutics, Inc. engages in the development of transformational treatments for patients with serious metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc..
...
...
Extended Summary

Akero Therapeutics

Akero Therapeutics, Inc., a clinical-stage company, engages in the development of transformational treatments for patients with serious metabolic diseases, including non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Its lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. The company is also conducting a Phase 2b clinical trial to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Related Results

...
February 03, 2024 12:49 (London Time)

Akero Therapeutics

Akero Therapeutics has a beta of -0.43, indicating that its share price is 143% less volatile than the S&P 500. Kamada has higher revenue and earnin…
Sector: Biotechnology
Ticker: AKRO
Sentiment: -0.34
MarketCap: 1,159,320,584.0
High: 20.87 Low: 19.96

Open: 20.59 Close: 20.81 Change: 0.22

Read more →
...
November 19, 2023 8:25 (London Time)

Akero Therapeutics

Akero Therapeutics stock crashed 65% on Tuesday: what happened? Akero Therapeutics is a clinical-stage company developing transformational treatment…
Sector: Biotechnology
Ticker: AKRO
Sentiment: -0.4993
MarketCap: 870,186,810.0
High: 15.66 Low: 14.41

Open: 14.5 Close: 15.62 Change: 1.12

Read more →
...
May 24, 2023 1:23 (London Time)

Akero Therapeutics

Akero Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing transformational treatments for patients with…
Sector: Biotechnology
Ticker: AKRO
Sentiment: 0.743
MarketCap: 2,208,074,572.0
High: 48.14 Low: 43.34

Open: 45.62 Close: 44.34 Change: -1.28

Read more →
...
January 30, 2024 3:33 (London Time)

Akero Therapeutics

Akero Therapeutics, Inc. (NASDAQ:AKRO) target price at $40.86 - defense world.com. Brokerages Set Akero therapeuticutics, inc. (nasdaq:akro) Target …
Sector: Biotechnology
Ticker: AKRO
Sentiment: 0.4019
MarketCap: 1,231,743,302.0
High: 23.64 Low: 21.75

Open: 22.11 Close: 23.57 Change: 1.46

Read more →
...
June 06, 2023 23:42 (London Time)

Akero Therapeutics

Akero Therapeutics is a clinical-stage pharmaceutical company that develops treatments for non-alcoholic steatohepatitis (NASH) Wall Street Analysts…
Sector: Biotechnology
Ticker: AKRO
Sentiment: 0.923
MarketCap: 2,878,031,365.0
High: 53.68 Low: 49.9

Open: 52.07 Close: 53.24 Change: 1.17

Read more →
Search
Happening Now
Categories